Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Human Immunodeficiency Virus Type 1 (HIV-1) Infection”

1,908 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,908 results

Not applicableStudy completedNCT00713531
What this trial is testing

Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand

Who this might be right for
HIV Infections
SEARCH Research Foundation 992
Testing effectiveness (Phase 2)Study completedNCT00711230
What this trial is testing

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients

Who this might be right for
HIV Infection
Genetic Immunity 36
Large-scale testing (Phase 3)Study completedNCT00946595
What this trial is testing

Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 420
Large-scale testing (Phase 3)Ended earlyNCT00122551
What this trial is testing

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 400
Large-scale testing (Phase 3)Study completedNCT02616029
What this trial is testing

Study to Evaluate Switching to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) Fixed Dose Combination (FDC) in Virologically-Suppressed HIV-1 Infected Adults Harboring the Archived Isolated NRTI Resistance Mutation M184V/M184I

Who this might be right for
HIV-1 Infection
Gilead Sciences 66
Testing effectiveness (Phase 2)Study completedNCT02071095
What this trial is testing

Enhancement by Poly-ICLC During HIV-1 Infection

Who this might be right for
HIV-1 Infected Adults With Chronic HIV-1 Infection
Nina Bhardwaj 15
Large-scale testing (Phase 3)Study completedNCT02987530
What this trial is testing

National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection

Who this might be right for
HIV-1 Infection
ANRS, Emerging Infectious Diseases 101
Large-scale testing (Phase 3)Study completedNCT03016533
What this trial is testing

Dolutegravir Study in HIV-1 Participants Completing IMPAACT Studies P1093 and P2019

Who this might be right for
HIV Infections
ViiV Healthcare 100
Early research (Phase 1)Study completedNCT00001644
What this trial is testing

Use of Combined Antiretroviral Therapy to Determine Sites of Persistent HIV Infection

Who this might be right for
HIV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 42
Large-scale testing (Phase 3)Study completedNCT01363011
What this trial is testing

Cobicistat-containing Highly Active Antiretroviral Regimens in HIV-1 Infected Patients With Mild to Moderate Renal Impairment

Who this might be right for
Acquired Immunodeficiency SyndromeHIV Infections
Gilead Sciences 106
Not applicableStudy completedNCT00476671
What this trial is testing

Neurocognitive Impairment and Psychiatric Comorbidities in HIV-1

Who this might be right for
HIV Infections
The HIV Netherlands Australia Thailand Research Collaboration 100
Testing effectiveness (Phase 2)Temporarily pausedNCT03312244
What this trial is testing

Pyridostigmine as Immunomodulator in People Living With HIV

Who this might be right for
HIV-1-infectionCD4+ T LymphocytopeniaImmune Deficiency+1 more
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 60
Not applicableUnknownNCT00954863
What this trial is testing

Genotypic Resistant HIV Strains in Taiwan

Who this might be right for
HIV-1HIV Infections
National Taiwan University Hospital 200
Early research (Phase 1)Study completedNCT00000977
What this trial is testing

Active Immunization of Asymptomatic, HIV-Infected Individuals With Recombinant GP160 HIV-1 Antigen: A Phase I/II Study of Immunogenicity and Toxicity

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 52
Post-approval studies (Phase 4)Study completedNCT04549467
What this trial is testing

Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test

Who this might be right for
HivHIV-1-infection
Fundacion IDEAA 244
Testing effectiveness (Phase 2)Ended earlyNCT02605304
What this trial is testing

12 Weeks of Ledipasvir (LDV)/Sofosbuvir (SOF) With Weight-based Ribavirin vs. 24 Weeks of LDV/SOF

Who this might be right for
HIV-1 InfectionHepatitis C
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 7
Early research (Phase 1)Study completedNCT00001044
What this trial is testing

A Phase I, Multicenter, Randomized, Double-Blind, Placebo-Controlled HIV-1 Vaccine Trial to Evaluate the Safety and Immunogenicity of rgp120/HIV-1MN (Genentech) in Combination With QS21 Adjuvant and/or Alum in Healthy Adults.

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 80
Testing effectiveness (Phase 2)Study completedNCT01717287
What this trial is testing

The Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248)

Who this might be right for
HIV Infection
Merck Sharp & Dohme LLC 32
Large-scale testing (Phase 3)Study completedNCT00711009
What this trial is testing

Study Comparing Lopinavir/Ritonavir (LPV/r) + Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF) With a Nucleoside Sparing Regimen Consisting of Lopinavir/Ritonavir + Raltegravir (RAL)

Who this might be right for
Human Immunodeficiency Virus Infection
Abbott 206
Post-approval studies (Phase 4)Study completedNCT00127972
What this trial is testing

2NN & CHARM Long-Term Follow-up Study

Who this might be right for
HIV Infections
International Antiviral Therapy Evaluation Center 763
Load More Results